Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8726
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma ; day:16 ; month:10 ; year:2020 ; pages:1-11
World journal of urology ; (16.10.2020), 1-11
- Urheber
-
Pradere, Benjamin
D'Andrea, David
Schuettfort, Victor M.
Foerster, Beat
Quhal, Fahad
Mori, Keiichiro
Abufaraj, Mohammad
Margulis, Vitaly
Deuker, Marine
Briganti, Alberto
Muilwijk, Tim
Hendricksen, Kees
Lotan, Yair
Karakiewic, Pierre
Shariat, Shahrokh F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00345-020-03479-3
- URN
-
urn:nbn:de:101:1-2020113023205098509045
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pradere, Benjamin
- D'Andrea, David
- Schuettfort, Victor M.
- Foerster, Beat
- Quhal, Fahad
- Mori, Keiichiro
- Abufaraj, Mohammad
- Margulis, Vitaly
- Deuker, Marine
- Briganti, Alberto
- Muilwijk, Tim
- Hendricksen, Kees
- Lotan, Yair
- Karakiewic, Pierre
- Shariat, Shahrokh F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
Comparison between urothelial and non-urothelial urethral cancer
Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
Comparison between urothelial and non-urothelial urethral cancer
Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
Comparison between urothelial and non-urothelial urethral cancer
Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma